Status:
TERMINATED
Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
Nationaal Kankerplan
Conditions:
Inoperable Early Stage Non-small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Surgical resection with mediastinal lymph node sampling is currently the therapy of choice for early stage (I-II) non-small cell lung cancer (NSCLC). Selected patients unwilling or unable to tolerate ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Proof of cT1a/b - 2a/b N0M0 NSCLC
- Informed Consent signed
- Resectable tumour
- \> 18 years old
- men and women
Exclusion
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT01138748
Start Date
November 1 2010
End Date
October 1 2012
Last Update
February 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium